Jazz Pharma Still Loved At UBS, Firm Hikes Price Target To $210 By: Benzinga via Benzinga June 29, 2015 at 11:11 AM EDT In a report published Monday, UBS analyst Marc Goodman maintained a Buy rating on Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ: ... Read More >> Related Stocks: Jazz Pharma Plc UBS Group Ag ADR